Evidence map›Paper›PMID 24292793›Full record

ArticleStem cells translational medicine2014

Generation of functional insulin-producing cells from mouse embryonic stem cells through 804G cell-derived extracellular matrix and protein transduction of transcription factors.

Taku Kaitsuka, Hirofumi Noguchi, Nobuaki Shiraki, Takuya Kubo, Fan-Yan Wei, Farzana Hakim, Shoen Kume, Kazuhito Tomizawa

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Bioencapsulation technologies in tissue engineering.Journal of applied biomaterials & functional materials · 2016
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Taku KaitsukaDepartment of Molecular Physiology, Faculty of Life Sciences, Department of Stem Cell Biology, Institute of Molecular Embryology and Genetics, and The Global Center of Excellence Program, Kumamoto University, Kumamoto, Japan; Department of Surgery, Chiba-East National Hospital, National Hospital Organization, Chiba, Japan; Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency, Saitama, Japan.
Hirofumi Noguchi
Nobuaki Shiraki
Takuya Kubo
Fan-Yan Wei
Farzana Hakim
Shoen Kume
Kazuhito Tomizawa
Kumamoto University · JPJapan Science and Technology Agency · JPNational Hospital Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Embryonic stem (ES) and induced pluripotent stem (iPS) cells have potential applications to regenerative medicine for diabetes; however, a useful and safe way to generate pancreatic β cells has not been developed. In this study, we tried to establish an effective method of differentiation through the protein transduction of three transcription factors (Pdx1, NeuroD, and MafA) important to pancreatic β cell development. The method poses no risk of unexpected genetic modifications in target cells. Transduction of the three proteins induced the differentiation of mouse ES and mouse iPS cells into insulin-producing cells. Furthermore, a laminin-5-rich extracellular matrix efficiently induced differentiation under feeder-free conditions. Cell differentiation was confirmed with the expression of the insulin 1 gene in addition to marker genes in pancreatic β cells, the differentiated cells secreted glucose-responsive C-peptide, and their transplantation restored normoglycemia in diabetic mice. Moreover, Pdx1 protein transduction had facilitative effects on differentiation into pancreatic endocrine progenitors from human iPS cells. These results suggest the direct delivery of recombinant proteins and treatment with laminin-5-rich extracellular matrix to be useful for the generation of insulin-producing cells.

Indexed as

Diabetes Mellitus, ExperimentalAnimalsBasic Helix-Loop-Helix ProteinsCell DifferentiationCell LineEmbryonic Stem CellsExtracellular MatrixGreen Fluorescent ProteinsHomeodomain ProteinsInsulinInsulin-Secreting CellsMaf Transcription Factors, LargeMiceNerve Tissue ProteinsProtein TransportTrans-ActivatorsBasic Helix-Loop-Helix ProteinsGreen Fluorescent ProteinsHomeodomain ProteinsInsulinMafa protein, mouseMaf Transcription Factors, LargeNerve Tissue ProteinsNeurogenic differentiation factor 1pancreatic and duodenal homeobox 1 proteinTrans-ActivatorsTranscription FactorsDiabetesEmbryonic stem cellsInduced pluripotent stem cellsPancreatic differentiationTranscription factors

Identifiers

PMID24292793
PMCPMC3902286
OpenAlexW2120767666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.